Sage Rhino Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Sell
23,912
-848
-3% -$9.46K 0.04% 322
2026
Q1
$268K Sell
24,760
-611
-2% -$5.23K 0.05% 213
2025
Q4
$155K Buy
25,371
+1,575
+7% +$9.4K 0.03% 298
2025
Q3
$123K Buy
23,796
+9,714
+69% +$55.8K 0.02% 288
2025
Q2
$83.5K Sell
14,082
-2,562
-15% -$15.4K 0.02% 270
2025
Q1
$137K Buy
16,644
+2,585
+18% +$21.7K 0.03% 251
2024
Q4
$116K Buy
14,059
+3,928
+39% +$31.5K 0.03% 256
2024
Q3
$77.5K Sell
10,131
-2,492
-20% -$23K 0.02% 270
2024
Q2
$131K Buy
12,623
+1,724
+16% +$18.9K 0.03% 230
2024
Q1
$130K Buy
+10,899
New +$121K 0.03% 219

Other funds holding PTEN

Sage Rhino Capital's PTEN Position: Q2 2026 in Review

Sage Rhino Capital reduced its Patterson-UTI (PTEN) stake by 3.4% in Q2 2026, selling an estimated $9.46K and leaving 23,912 shares worth $220K. The position accounts for 0.04% of the portfolio, ranked #322.

Sage Rhino Capital first reported a position in PTEN in Q1 2024 and has held it in 10 quarters since. The position peaked at $268K in Q1 2026. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Sage Rhino Capital held 23,912 shares of Patterson-UTI worth $220K as of Q2 2026.
  • Sage Rhino Capital sold 848 Patterson-UTI shares in Q2 2026, an estimated $9.46K.
  • Patterson-UTI made up 0.04% of Sage Rhino Capital's portfolio in Q2 2026, its #322 holding.
  • Sage Rhino Capital first reported a position in Patterson-UTI in Q1 2024 and has held it in 10 quarters since.
  • Sage Rhino Capital's Patterson-UTI position peaked at $268K in Q1 2026.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.